NEW YORK (GenomeWeb) – Molecular diagnostics firm Atlas Genetics today announced the completion of a Series C financing round that raised $20 million. 

Atlas will use the proceeds to accelerate the launch of its MDx system called io in Europe for the ultra-rapid diagnosis of infectious diseases, initiate clinical trials in the US, and expand its test menu for sexually transmitted diseases and hospital-acquired infections. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The United Nations is to consider a ban on field testing gene drives at a meeting being held next week, Technology Review reports.

The Associated Press reports that gene-edited food may soon be for sale.

The US Department of Health and Human Services is beginning a series of meetings on human fetal tissue research, Stat News reports.

In Cell this week: epigenetic change linked to glioblastomas, rare and low-frequency variants contributing to multiple sclerosis risk, and more.